Z-1389-2025 Class II Ongoing

Recalled by Immuno-Mycologics, Inc — Norman, OK

FDA device recall Z-1389-2025 was initiated by Immuno-Mycologics, Inc on Feb 10, 2025 and is designated Class II. Reason for recall: Candida Immunodiffusion Antigen may have reduced sensitivity which could result in false negative results. The recall status is ongoing. Affected quantity: 30 vials.

Recall details

Product Type
Devices
Report Date
Mar 26, 2025
Initiation Date
Feb 10, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
30 vials

Product description

Candida ID Antigen, REAG, AG, REF C50110, Vol 1 mL REF ID1001, Immy Fungal Antigens, Positive Controls, & Immunodiffusion (ID) plates for use in the ID test, RX only, IVD, CE

Reason for recall

Candida Immunodiffusion Antigen may have reduced sensitivity which could result in false negative results.

Distribution pattern

Worldwide - US Nationwide distribution in the states of CA and OK and the countries of Peru France, Austria, Venezuela.

Code information

Lot #: F4171005/UDI: 00816387020223

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1389-2025
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1389-2025. Report a data issue: hello@regdatalab.com.